Disogluside

InformationGlipizide Glipizide (CP-28720) is used to treat high blood sugar levels caused by a type of diabetes mellitus called type 2 diabetes.In vitroIn vivoCell Datacell lines：Concentrations：Incubation Time：Powder Purity:≥99%.

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

GW 590735 is a potent and selective PPARα agonist. GW 590735 shows EC 50 =4 nM on PPARα and at least 500-fold selectivity versus PPARδ and PPARγ. GW 590735 can be used for the research of dyslipidemia.In VivoGW 590735 (0.5-5 mg/kg: orally twice a

Application Potent and selective inhibitor of PKA. Biochem/physiol Actions Inhibitor Type: Kinase Physical form lyophilized powder Storage and Stability 2 years at -20&#176C in a desiccation chamber.

MF: C27H30O16 MF: 610.53 CAS: 52187-80-1 Purity: =97% by HPLC

Biochem/physiol Actions NG-497 is a non-cytotoxic, substrate-competitive, reversible and highly selective human/primate adipose triglyceride lipase (ATGL: IPLA2-zeta: PNPLA2) inhibitor (IC50 = 1 &#956:M, Ki = 0.5 &#956:M) with little activity

Biochem/physiol Actions NG-497 is a non-cytotoxic, substrate-competitive, reversible and highly selective human/primate adipose triglyceride lipase (ATGL: IPLA2-zeta: PNPLA2) inhibitor (IC50 = 1 &#956:M, Ki = 0.5 &#956:M) with little activity

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

Application Potassium disulfate (K 2 S 2 O 7 ) can be used: As a salt catalyst for the conversion of hemicellulose into reducing sugars such as xylose and galactose by mechanocatalysis . In the preparation of diacylbenzenes via Pd-catalyzed

Application Potassium disulfate (K 2 S 2 O 7 ) can be used: As a salt catalyst for the conversion of hemicellulose into reducing sugars such as xylose and galactose by mechanocatalysis . In the preparation of diacylbenzenes via Pd-catalyzed